Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2025-2031

Publication ID:

LPI07254716

Publication Date:

July 4, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Neuromodulation Devices and Implantable Infusion Pumps market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson"s disease, Epilepsy, etc.
The 鈥淣euromodulation Devices and Implantable Infusion Pumps Industry Forecast鈥� looks at past sales and reviews total world Neuromodulation Devices and Implantable Infusion Pumps sales in 2024, providing a comprehensive analysis by region and market sector of projected Neuromodulation Devices and Implantable Infusion Pumps sales for 2025 through 2031. With Neuromodulation Devices and Implantable Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromodulation Devices and Implantable Infusion Pumps industry.
This Insight Report provides a comprehensive analysis of the global Neuromodulation Devices and Implantable Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuromodulation Devices and Implantable Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Neuromodulation Devices and Implantable Infusion Pumps market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromodulation Devices and Implantable Infusion Pumps and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromodulation Devices and Implantable Infusion Pumps.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segmentation by Application:
Parkinson's Disease
Epilepsy
Pain
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Neuromodulation Devices and Implantable Infusion Pumps market?
What factors are driving Neuromodulation Devices and Implantable Infusion Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuromodulation Devices and Implantable Infusion Pumps market opportunities vary by end market size?
How does Neuromodulation Devices and Implantable Infusion Pumps break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Country/Region, 2020, 2024 & 2031
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Sacral Nerve Stimulation
2.2.4 Vagal Nerve Stimulation
2.2.5 Gastric Stimulation
2.2.6 Transcranial Magnetic Stimulation
2.2.7 Transcutaneous Electrical Stimulation
2.2.8 Other
2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2020-2025)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2020-2025)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2020-2025)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2020-2025)
2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2020-2025)
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Company (2020-2025)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2020-2025)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Company (2020-2025)
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2020-2025)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2020-2025)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Location Distribution
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region
4.1 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Geographic Region (2020-2025)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country/Region (2020-2025)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Country/Region (2020-2025)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.4 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
5 Americas
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2020-2025)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2020-2025)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2025)
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2020-2025)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2020-2025)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2025)
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2020-2025)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2020-2025)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2025)
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Country
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2020-2025)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2020-2025)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2025)
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
11.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
12 World Forecast Review for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region
12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
12.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Region (2026-2031)
12.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type (2026-2031)
12.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 St. Jude Medical
13.3.1 St. Jude Medical Company Information
13.3.2 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 St. Jude Medical Main Business Overview
13.3.5 St. Jude Medical Latest Developments
13.4 Synapse Biomedical
13.4.1 Synapse Biomedical Company Information
13.4.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Synapse Biomedical Main Business Overview
13.4.5 Synapse Biomedical Latest Developments
13.5 Nevro Corporation
13.5.1 Nevro Corporation Company Information
13.5.2 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Nevro Corporation Main Business Overview
13.5.5 Nevro Corporation Latest Developments
13.6 Neuropace
13.6.1 Neuropace Company Information
13.6.2 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Neuropace Main Business Overview
13.6.5 Neuropace Latest Developments
13.7 Cyberonics
13.7.1 Cyberonics Company Information
13.7.2 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cyberonics Main Business Overview
13.7.5 Cyberonics Latest Developments
13.8 Autonomic Technologies
13.8.1 Autonomic Technologies Company Information
13.8.2 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Autonomic Technologies Main Business Overview
13.8.5 Autonomic Technologies Latest Developments
13.9 Avery Biomedical
13.9.1 Avery Biomedical Company Information
13.9.2 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Avery Biomedical Main Business Overview
13.9.5 Avery Biomedical Latest Developments
13.10 Greatbatch Medical
13.10.1 Greatbatch Medical Company Information
13.10.2 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Greatbatch Medical Main Business Overview
13.10.5 Greatbatch Medical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂